{
  "ptid_time": "126_S_4743_2012-05-24",
  "img_path": "/data/qiuhui/data/adni/images/126_S_4743/2012-05-24/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 43,335 mm³, 12.5% above the reference mean. With a Z-score of 0.30 (61.8th percentile), this represents normal volume ; hippocampal volume measures 6,106 mm³, 19.2% below the reference mean. With a Z-score of -1.88 (3.0th percentile), this represents moderate atrophy; whole brain volume measures 1,115,710 mm³, 3.4% above the reference mean. With a Z-score of 0.44 (66.9th percentile), this represents normal volume ; entorhinal cortex volume measures 2,869 mm³, 30.0% below the reference mean. With a Z-score of -2.04 (2.1th percentile), this represents significant atrophy; fusiform gyrus volume measures 18,355 mm³, 2.6% below the reference mean. With a Z-score of -0.22 (41.3th percentile), this represents normal volume ; middle temporal gyrus volume measures 21,904 mm³, 2.6% above the reference mean. With a Z-score of 0.24 (59.4th percentile), this represents normal volume . ",
  "text_data": "Age is 70.1 years. Gender is Male. Education: 12 years. Handedness: Right. Race: White. Medical history: Head, Eyes, Ears, Nose and Throat; Cardiovascular; Dermatologic-Connective Tissue; Musculoskeletal; Endocrine-Metabolic; Renal-Genitourinary; Smoking. MMSE: 28.0. MoCA: 18.0. Logical Memory: 3.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.38 SUVR (significant elevated); Amyloid beta: 844.80 pg/mL (normal ); Total tau: 242.90 pg/mL (normal ); Phosphorylated tau: 22.83 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The patient shows significant atrophy in the hippocampus and entorhinal cortex (both below the 5th percentile), which are key regions affected in Alzheimer's disease (AD). Despite normal Aβ and tau biomarkers, the elevated AV45 (amyloid PET) suggests amyloid pathology. The MoCA score of 18 indicates cognitive impairment, while the MMSE of 28 is less sensitive. The discrepancy between biomarkers (normal CSF Aβ but elevated AV45) may reflect early amyloid deposition.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely due to Alzheimer's pathology given hippocampal/entorhinal atrophy and AV45 positivity).  \n\n**Confidence:** **Medium** (due to conflicting biomarkers—normal CSF Aβ/P-tau but elevated AV45—though structural and cognitive findings strongly suggest early AD-related MCI).",
  "timestamp": "2025-07-26T12:49:53.695017"
}